Clinical Trial Update: A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD [Phase 3]

View source ↗

Summary

Phase 3 pilot crossover trial comparing prophylactic Wilate to placebo for heavy menstrual bleeding in patients with von Willebrand disease; currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Wilate (von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: Unity Health Toronto | Conditions: Von Willebrand Diseases | Phase 3 | Status: RECRUITING